SCHEMBL20150393

SCHEMBL20150393

Cc1ccc(-c2ccc3c4ccc(-c5ccc(C)cc5C)cc4n(-c4ccc(C#N)cc4-c4nc(C)nc(C)n4)c3c2)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
GRM2 Q14416 1/20 0.35
S1PR1 P21453 1/20 0.32
CHEK1 O14757 1/20 0.32
KCNH2 Q12809 2/20 0.32
HRH2 P25021 1/20 0.32
HRH1 P35367 1/20 0.32
EGLN2 Q96KS0 4/20 0.31
ITK Q08881 1/20 0.31
ABL1 P00519 1/20 0.31
MAP4K1 Q92918 1/20 0.31
CRHR1 P34998 2/20 0.31
NSD2 O96028 1/20 0.31
CASP3 P42574 1/20 0.30
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150413 0.95 PTGER4 (0.35) CYP11B1CYP11B2GRM2S1PR1CHEK1
SCHEMBL20150352 0.93 CYP11B1 (0.37) CYP11B1CYP11B2GRM2S1PR1CHEK1
SCHEMBL20150391 0.89 CHEK1 (0.36) CYP11B1CYP11B2GRM2CHEK1ITK
SCHEMBL20150376 0.89 ITK (0.36) GRM2ITKCRHR1CASP3
SCHEMBL20115006 0.88 CYP11B1 (0.37) CYP11B1CYP11B2CHEK1ABL1CRHR1
SCHEMBL20156263 0.88 CYP11B1 (0.35) CYP11B1CYP11B2GRM2CHEK1EGLN2
SCHEMBL20114687 0.88 PTGER4 (0.35) CYP11B1CYP11B2GRM2S1PR1CHEK1
SCHEMBL20150412 0.88 CASP3 (0.35) CYP11B1CYP11B2GRM2CHEK1EGLN2
SCHEMBL20114589 0.87 STS (0.35) CYP11B1CYP11B2CHEK1CRHR1CASP3
SCHEMBL20648264 0.87 KMT2A (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 CYP11B1 1765/4885CYP11B2 1259/4885GRM2 1828/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 CYP11B1 1765/4885CYP11B2 1259/4885GRM2 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.